vTv Therapeutics Inc. (VTVT) Financials

VTVT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 11.0 million 29.6 million
2023-09-30 14.9 million 29.4 million
2023-06-30 22.4 million 28.8 million
2023-03-31 28.8 million 48.0 million

VTVT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -2.9 million 403000
2023-09-30 -4.8 million 433000
2023-06-30 -6.2 million 399000
2023-03-31 -5.2 million 343000

VTVT Net Income

No data available :(

VTVT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 9.4 million - 338000
2023-09-30 8.2 million - 378000
2023-06-30 12.6 million - 417000
2023-03-31 18.8 million - 454000

VTVT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.1 million
2023-09-30 81.5 million
2023-06-30 81.5 million
2023-03-31 81.5 million

VTVT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 2.1 million 2.6 million -
2023-09-30 - 2.8 million 2.5 million -
2023-06-30 - 4.7 million 3.3 million -
2023-03-31 - 3.9 million 3.5 million -

VTVT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 23000
2023-09-30 - 22000
2023-06-30 9000 23000
2023-03-31 - 22000

VTVT

Price: $23.69

52 week price:
7.38
39.60

Earnings Per Share: -9.71 USD

P/E Ratio: -0.96

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 36900

Ebitda: -11.5 million

Market Capitalization: 60.5 million

Links: